415 results on '"Targan, Stephan R."'
Search Results
2. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn’s Disease
3. Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab
4. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
5. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study
6. DR3 Regulates Intestinal Epithelial Homeostasis and Regeneration After Intestinal Barrier Injury
7. Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8+ T cells.
8. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease
9. TL1A primed dendritic cells activation exacerbated chronic murine colitis
10. A role for BATF3 in TH9 differentiation and T-cell-driven mucosal pathologies
11. Malassezia Is Associated with Crohn’s Disease and Exacerbates Colitis in Mouse Models
12. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis
13. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome
14. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases
15. Enhanced Utilization of Induced Pluripotent Stem Cell–Derived Human Intestinal Organoids Using Microengineered Chips
16. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn’s Disease
17. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
18. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo
19. A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn’s Disease and Human Gut Microbiome Composition
20. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
21. Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans
22. Genetic Variants Synthesize to Produce Paneth Cell Phenotypes That Define Subtypes of Crohn's Disease
23. Late-Onset Crohn’s Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics
24. Serological, genetic and clinical associations with increased health‐care resource utilization in inflammatory bowel disease
25. Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn’s Colitis
26. Multiple activating and repressive cis-promoter regions regulate TNFSF15 expression in human primary mononuclear cells
27. Colorectal cancer screening and surveillance in Crohn's colitis
28. Abatacept for Crohn's Disease and Ulcerative Colitis
29. Constitutive TL1A Expression under Colitogenic Conditions Modulates the Severity and Location of Gut Mucosal Inflammation and Induces Fibrostenosis
30. Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice
31. Future Therapeutic Approaches for Inflammatory Bowel Diseases
32. Substance P Induces CCN1 Expression via Histone Deacetylase Activity in Human Colonic Epithelial Cells
33. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits
34. Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion.
35. Assessing Health Status in Inflammatory Bowel Disease Using a Novel Single-Item Numeric Rating Scale
36. Molecular Imaging of Murine Intestinal Inflammation With 2-Deoxy-2-[18F]Fluoro-d-Glucose and Positron Emission Tomography
37. Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
38. TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation
39. TL1A Selectively Enhances IL-12/IL-18-Induced NK Cell Cytotoxicity against NK-Resistant Tumor Targets
40. Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
41. Microbiota activation and regulation of innate and adaptive immunity
42. Insights into IBD pathogenesis
43. Recent advances in IBD pathogenesis: Genetics and immunobiology
44. Ex Vivo Induction of mRNA in Human Whole Blood as a New Platform of Drug and Dietary Supplement Development
45. Family History and Serology Predict Crohn’s Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis
46. Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis?
47. Predicting a Change in Diagnosis From Ulcerative Colitis to Crohn’s Disease: A Nested, Case-Control Study
48. Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
49. NOD2 Variants and Antibody Response to Microbial Antigens in Crohn’s Disease Patients and Their Unaffected Relatives
50. High-Level Serum Antibodies to Bacterial Antigens Are Associated with Antibiotic-Induced Clinical Remission in Crohn's Disease: A Pilot Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.